The INSERM U1070 unit aim to optimize the antibiotic usage with a triple target: To increase their efficacy, To control the toxicity and To limit the emergence of antibiotic resistance. In order to do so, we are developping innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation.
| Website | https://phar.labo.univ-poitiers.fr/ |
| Revenue | $494 million |
| Employees | 13 (5 on RocketReach) |
| Founded | 2012 |
| Address | 1, Rue Georges Bonnet, Poitiers, Nouvelle-Aquitaine 86000, FR |
| Industry | Think Tanks |
Looking for a particular Inserm U1070 employee's phone or email?
The Inserm U1070 annual revenue was $494 million in 2026.
5 people are employed at Inserm U1070.
Inserm U1070 is based in Poitiers, Nouvelle-Aquitaine.